In dogs with myocardial infarction, produced by a standard technic, rapid persistent ectopic ventricular tachycardia develops. Intravenous quinidine lactate and quinidine gluconate effectively control the arrhythmia in 56 to 60 per cent of the animals, but produce toxic reactions in many of them. Morphine sulfate prevents vomiting and diarrhea from quinidine, but does not prevent convulsive movements. The most effective treatment of the arrhythmia was by use of morphine followed by quinidine gluconate. This combination was successful in 89 to 100 per cent of the cases. Principles for guidance in the treatment of severe ventricular arrhythmias have been drawn from these studies.
Q UINIDINE has long been known to be effective in terminating ventricular tachycardias. '-6 In some cases, however, it has failed,5' 6 and ventricular tachycardias have been produced by its administration.1' 3', Fatal ventricular fibrillation has occurred during slow intravenous administration of quinidine to a patient with ventricular tachycardia which developed following myocardial infarction.8 Ventricular premature beats, brief paroxysms of ventricular tachycardia and transient ventricular fibrillation have been precipitated by quinidine in patients who were subject to spontaneous episodes of this kind. 9 Toxic manifestations of other kinds, especially nausea and vomiting, are of frequent occurrence upon intravenous administration of quinidine even when it succeeds in the abolition of abnormal cardiac rhythms. 2' 4 Quinidine is widely regarded as the drug of choice for the treatment of ventricular tachycardias in spite of the untoward occurrences.'
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It is apparent, therefore, that there is need for carefully controlled experiments to determine and analyze the conditions under which success, failure, and exacerbation of the arrhythmia result from its use. In the past, controlled study of the effectiveness of drugs and procedures in the suppression of dangerous cardiac arrhythmias of kinds similar to those which occur in patients (except arrhythmias induchd by drugs) has been severely limited by the lack of a method by which such arrhythmias could be produced in experimental animals.
A technic for the production in dogs of a high frequency ectopic ventricular tachycardia associated with myocardial infarction has recently been developed.'0 Ninety per cent or more of the animals prepared by the standardized technic develop ectopic ventricular tachycardias with rates of 160 per minute or higher and rates of 200 to 260 were developed in 53 per cent of a recently tabulated series of 32 consecutive dogs. In an occasional dog the maximal ectopic rate reaches 300. The delayed ventricular tachycardia has its onset four and one-half to eight hours after occlusion of the artery, that is, after a period of occlusion that approximates the minimal duration of ischemia that is required to produce microscopically visible evidence of necrosis.'0-'2 After the onset of the Circulation, Volume number of other tests adequate administration of the drug was interfered with by severe toxic reactions. In later experiments it was learned that the vomiting and diarrhea produced by quinidine could be totally eliminated by morphine (see sections on toxicity and on quinidine compounds after morphine). In view of these findings, the percentage of favorable results in this first series should be regarded as conservative.
Graphic and detailed representations of the results of administration of quinidine comments, appeared to be in good condition at all times.
An experiment showing unusually effective suppressor action is represented in figure 2 .
The first dose, 10 mg. per Kg., restored an entirely normal rhythm for a few minutes, and the rate of ectopic discharging was kept at a level below one-half the control rate for an hour, though ectopic complexes were returning rapidly at the end of the hour. The addition of a second dose eliminated all ectopic activity for about two and one-half hours, after which there maintained at less than one-half of the pretreatment rate for more than four hours. These most favorable therapeutic results were found in six dogs or 60 per cent of the total number of animals. These percentages are slightly higher than the corresponding ones obtained with quinidine lactate, but convulsive movesuppressor action is to be found between the two quinidine compounds.
A chart of one of the experiments with quinidine gluconate is reproduced in figure 3 . This animal had a ventricular tachycardia with a rate of 240 to 250 on the morning of the first postoperative day prior to the first injection of quinidine gluconate. Each dose lowered the ectopic rate immediately, and following each reduction there was a prompt rise toward the preceding high level. However, cumulative action was shown in the fact that after each additional dose the ectopic rate reached a new low level, and following the fifth dose the rise was much slower than the rises following earlier doses. After the sixth dose there was yet another rise and spontaneous fall after which no further doses were needed. Thirteen hours after the last dose the ectopic rate was only 30 per minute. This experiment is an example of successful control of a severe ventricular tachycardia by a sufficient number of doses more widely spaced than the 30 minute intervals which were found to be optimal for relatively quick suppressor effects.
Quinidine Lactate following Morphine in
Strongly Analgesic Doses. Six tests of the ectopic suppressor effects of quinidine lactate following morphine were carried out in five dogs. In four of the six tests ectopic activity was abolished for a time and maintained at a frequency less than one-half of the control rate for more than four hours. The two failures were first and second postoperative day tests in the same resistant animal. Effective suppression of ectopic impulses was achieved in four of five animals, but one of them died in standstill one hour after the last dose. In three of the tests, all in the successfully controlled group, there was a significant diminution in ectopic frequency, though not a large one, between the injection of morphine and the first dose of quinidine lactate.
Quinidine Gluconate following Morphine. Nine tests of the effects of quinidine gluconate following morphine upon ectopic ventricular tachycardia were performed in nine dogs. All ectopic activity was eliminated temporarily in each of the animals and the ectopic rate was below one-half of the control rate longer than four hours (six hours to permanent) in eight of them and possibly the other one also. Unfortunately records from one animal were discontinued two and one-half hours after ectopic activity was brought under control. At least 89 per cent, and possibly 100 per cent, of the morphine-quinidine gluconate animals belong in the well-controlled group. Between the administration of morphine and the first dose of quinidine gluconate the ectopic frequency declined significantly in six of the nine dogs. This observation together with a similar one in the morphine-quinidine lactate experiments may indicate that morphine alone has a minor ectopic impulse suppressor effect, but it appears more probable that the inconstant reductions in frequency resulted from general sedation.
Toxic Reactions. Vomiting, diarrhea, and convulsive movements figured prominently in the results of both quinidine compounds, gluconate and lactate. Since the experiments were performed for the study of the suppressor effects of these drugs upon ectopic impulses, the number of 10 mg. per Kg. doses administered was determined by the persistence, disappearance, and recurrence of ectopic activity, except that in some experiments the administration of quinidine had to be interrupted or postponed because of the severe toxic reactions.
In the 39 tests with quinidine lactate alone vomiting occurred in 10, or 26 per cent, and convulsive movements in nine, or 23 per cent. Diarrhea accompanied the vomiting in a few experiments, and in one test defecation without vomiting occurred after each dose. Quinidine gluconate alone produced vomiting in three of 13 tests, or 23 per cent, and convulsive movements in one, or 8 per cent. The incidence of vomiting was about equal with the two quinidine compounds, but convulsions occurred in a significantly higher percentage of cases and were more prolonged in the experiments with quinidine lactate.
In the 15 tests in which morphine was given one to three and one-half hours prior to the first dose of quinidine (six with lactate, nine with gluconate), no vomiting or diarrhea occurred. Convulsions occurred in three. Morphine was administered subcutaneously in all trials. The doses in milligrams per kilogram were 5 in nine trials, 4.5 in two trials, 2 in two trials, 7 in one trial, and 7.5 in one trial.
The administration of morphine to a dog commonly induces vomiting. When repeated doses of morphine were injected, however, only the first one induced vomiting. Morphine gave complete protection against the induction of vomiting by additional morphine (see Leake'3) just as it protected against the induction of vomiting and diarrhea by quinidine.
Blood Pressure. Systolic, diastolic, and mean blood pressures were recorded from the femoral artery in a number of experiments via a small plastic catheter connected with a Statham gage transducer modified for use with a carrierfrequency amplifier. * A Sanborn Poly-Viso Cardiette recorded the pressure tracing and electrocardiogram simultaneously (fig. 4) Pulse pressures were significantly reduced during the dip in mean pressures in a number of trials in our series. This suggests that the systolic discharge was reduced, but does not prove it because the femoral pulse pressure is greatly influenced by superimposed waves which are subject to reduction by a lowering of the peripheral resistance. Experiments with skeletal muscle and perfused hearts, summarized by Sollmann,20 support the view that quinidine weakens contraction.
Vasodilatation appears to be a very sensitive reaction to quinidine, and it is probable that this is the chief cause of the decline in mean blood pressure that follows the injection of a small or moderate dose. Following a very large dose or a succession of doses within a brief period, weakening of the myocardium and vasodilatation both probably contribute to the production of hypotension. Production Two.of the six animals that died during testing exhibited intense dyspnea. One of them had only a moderate dyspnea before the first dose of quinidine, but the degree of dyspnea became more severe after each dose. This animal died five minutes,,-foer the i'_jection of the third dose. The other fatality case with intense dyspnea exhibited the dyspnea prior to the administration of quinidine and died after only one dose, 10 mg. per Kg. In certain other animals, some increase in respiratory movements followed the administration of quinidine, but these increases were moderate and lasted for only a few minutes, coinciding with the brief period of reduced blood pressure that was commonly observed. Dyspnea was produced by quinidine in only the one animal cited.
Dyspnea was rare in the 50 dogs with myocardial infarction used in this study. In addition to the two fatality cases, this sign was noted in the protocol of only one other dog, and that observation was on the third postocclusion day when the dog had a normal heart rhythm with a rate of 90. The dog had received no treatment since the first postocclusion day when a rapid ventricular tachycardia was brought under control by three doses of quinidine gluconate.
Blood pressure was recorded continuously during the quinidine tests in 11 Levine.5 In their series of 107 patients with paroxysmal ventricular tachycardia, 79 cases, or 74 per cent of the series, had coronary disease as the underlying cause of the tachycardia. In 44 cases, the attack was associated with acute myocardial infarction. The onset of the ventricular tachycardia occurred most often on the first day of the infarction, though the incidence was high on each day of the first two weeks. The finding of most frequent onset on the first day conforms to the observations in the dog with a large infarct.'0
The onset of tachycardia in some patients after a delay of a number of days differs from the dog with its maximal delay of eight hours. It is possible, however, that in some patients the initial symptoms resulted from obstruction of a relatively small artery which did not produce ectopic activity, and that the ventricular tachycardia was produced some days later as a result of additional occlusions or extension of the thrombosis with enlargement of the necrotizing mass of muscle. The differences in time of onset of the tachycardia with respect to time of occlusion may be apparent differences only.
In the cases of Armbrust and Levine the attacks of tachycardia were of two kinds, intermittent and persistent. The intermittent attacks were short paroxysms, lasting seconds or minutes, which ceased spontaneously or were readily controlled by therapy. fig. 4 ) reveals evidence that the abnormal complexes must be due to discrete ectopic ventricular impulses, and not to re-entrant conduction. Re-entrant conduction would be continuous conduction within intraventricular circuits. Intraventricular conductionl is represented in the electrocardiogram by the Q11S deflection. Therefore re-entrant conductioni in the ventricles, if it existed, would produce continuous QRS complexes, that is, each QRS would be joined to the next one before and after. This is clearly not to be found in a great! majority of records. In the ventricular tachycardia record reproduced in the control electrocardiogram of figure 4 the QRS deflections are widely separated from each other, occupying no more than about one-fifth of the total time in the record instead of the entire time as continuous intravent ricular conduction would require. As the frequency of abnormal complexes is reduced by treatment, the separations become wider. In extremely fast ventricular tachyeardias, 300 per minute and above, the wide QRS deflections that commonly are found in such frequencies often appear to be joined or nearly so. Under these conditions there is grave danger of a change from ventricular tachycardia to ventricular fibrillation, a condition that is characterized by continuous conduction.25 In view of the universally branching syncytium that makes up the musculature of the ventricles, it is highly improbable that reentrant conduction could occur in a cyclic manner in the ventricles for more than one or two beats before conduction would become disorganized into fibrillation. It is concluded that the ventricular tachycardia results from ectopic impulses arising in ventricular muscle. In previous papers evidence that these impulses arise in the boundary of the infarct has been presented26'27 and the probable excitatory factors discussed."0 The reduction of the ventricular tachycardia by quinidine therefore is attributed to its suppressor action upon ectopic pacemakers in agreement with Gold.2 Clinical Implications. The similarities in the reactions of dogs with persistent high frequency ventricular tachycardias accompanying myocardial infarction to the reported reactions of patients with similar tachyeardias, following intravenously administered quinidine compounds, suggest that observations made upon this kind of animal preparation may be of value in deriving principles for the improvement of treatment of this kind of severe ventricular arrhythmia.
The main conclusions of a practical nature which can be drawn from the present series of experiments are the following: (a) In animals that died after only a small amount of quinidine exhibited intense dyspnea, hypotension, or prolongation of the normally initiated QRS complex by as much as 75 to 100 pet cent of the control. These are regarded as important warning signs that quinidine should be withheld or that caution must be used in administering any further doses. The four fatal cases reported by Armbrust and Levine5 were described as having pulmonary edema, congestive heart failure, and shock. (e) It is not necessary to eliminate all ventricular ectopic beats, and in some cases it is dangerous to attempt to do so. A reduction of the rate of an ectopic ventricular tachycardia from 200 to 250 per minute to 100 will abolish danger of ventricular fibrillation27 and may be calculated to improve pumping action enough to markedly reduce the danger of cardiac and circulatory failure. (f) During the treatment of a persistent high frequency ventricular tachycardia with quinidine, and other ectopic suppressor drugs as well, the constant presence and frequent use of an electrocardiograph should be required. This is necessary in order to make use of the principles summarized in c, d, and e.
SUMMARY
A method of producing animal preparations with rapid, persistent, ectopic ventricular tachycardia associated with myocardial infarction has been developed. These animals duplicate some of the major features exhibited by patients with myocardial infarction in whom a severe ventricular arrhythmia arises, including types of arrhythmia and reactions to quinidine.
Four series of experiments were performed with these animal preparations. The tests made in the four groups were as follows: (1) tests with quinidine lactate alone, (2) tests with quinidine gluconate alone, (3) tests with morphine sulfate followed by quinidine lactate, and (4) tests with morphine sulfate followed by quinidine gluconate.
In series 1, 2, and 3 the percentages of animals in which successful control of the arrhythmia was achieved in one or more tests were 54, 60, and 60, respectively. No significant difference appears in these results. In series 4, in which morphine sulfate was followed by quinidine gluconate successful control was achieved in 89 to 100 per cent of the animals. These results are regarded as therapeutically superior to those of the other three groups. Vomiting, diarrhea, and convulsions complicated a number of the experiments. The incidence of vomiting was about equal following quinidine gluconate and lactate. The incidence of convulsions was greater following quinidine lactate.
Morphine sulfate, 5 mg. per Kg., stopped or completely prevented vomiting and diarrhea from both quinidine preparations. Morphine did not stop or prevent convulsions.
During injections the blood pressure declined somewhat in almost all cases. In one animal the pressure rose following some injections.
Paroxysms of ectopic ventricular tachycardia were induced by quinidine injections in three of the 50 animals. Convulsive movements accompanied the paroxysms in two animals. The unusual paroxysms are attributed to increased excitation of the central nervous system and consequent sympathoadrenal stimulation of the heart.
Study of the six fatalities indicates that quinidine administration may be especially dangerous in the presence of marked dyspnea or pronounced hypotension. Prolongation of QRS is not present to serve as a warning sign in all cases, but when it does exist in marked degree, administration of quinidine should be stopped.
Evidence is presented to show that the abnormal rhythm is due to ectopic impulses and not to re-entrant conduction. The reduction in abnormal activity by quinidine is due to suppression of ectopic pacemakers.
From the observations a list of principles which should be of value in the treatment of severe ventricular tachycardias has been formulated.
